Endometrial safety and bleeding patterns during a 2-year study of 1 or 2 mg 17β-estradiol combined with sequential 5-20 mg dydrogesterone

By Ferenczy A.   Gelfand M. M.   van de Weijer P. H. M.   Rioux J. E.  

Climacteric, Vol. 5, Iss. 1, 2002-03 ,pp. : 26-35

Informa Healthcare

Access to resources Recommend Favorite

The long-term effects of low-dose 17β-estradiol and dydrogesterone hormone replacement therapy on 24-h ambulatory blood pressure in hypertensive postmenopausal women: a 1-year randomized, prospective study

By Kaya C.   Cengiz S. Dincer   Cengiz B.   Akgun G.  

Climacteric, Vol. 9, Iss. 6, 2006-12 ,pp. : 437-445

Informa Healthcare

Access to resources Recommend Favorite

One-year randomized study of the endometrial safety and bleeding pattern of 0.25 mg drospirenone/0.5 mg 17β-estradiol in postmenopausal women

By Genazzani A. R.  

Climacteric, Vol. 16, Iss. 4, 2013-08 ,pp. : 490-498

Informa Healthcare

Access to resources Recommend Favorite

Low-dose oral combination of 17β-estradiol and norethisterone acetate in postmenopausal women decreases factor VII, fibrinogen, antithrombin and plasminogen activator inhibitor-1

By Borgfeldt C.   Li C.   Samsioe G.  

Climacteric, Vol. 7, Iss. 1, 2004-01 ,pp. : 78-85

Informa Healthcare

Access to resources Recommend Favorite

Drospirenone with 17β-estradiol in the postmenopausal woman with hypertension

By White W. B.  

Climacteric, Vol. 10, Iss. 1, 2007-01 ,pp. : 25-31

Informa Healthcare

Access to resources Recommend Favorite